CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 210 enrolled
Drug / intervention
Aerobic Exercisebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04307407
NCT04307407N/ACompleted

The Cause Trial: A Randomized Trial of Aerobic Exercise on CVD Risk Factors in Breast Cancer Survivors

Norwegian School of Sport Sciences·interventional·Posted Mar 13, 2020·Updated Mar 3, 2023

In Brief

A clinical study evaluating Aerobic Exercise for Breast Cancer. Completed, enrolled 210 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the effects of aerobic exercise to usual care in women treated with chemotherapy and radiation therapy for non-metastatic breast cancer

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesNorway

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 13, 2020
Enrollment StartSep 8, 2020
Primary CompletionMar 2, 2023
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 6.3 years ago

Interventions

Aerobic Exercisebehavioral

Participants will be randomized to supervised aerobic exercise or standard care. Women with no current or past malignant disease will comprise the reference group and will be matched for age to participants in the Aerobic Exercise arm